Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Coherus Oncology Inc
NASDAQ:CHRS
Coherus Oncology Inc
NASDAQ:CHRS
Price:
1.145
USD
-1.29%
Market Closed
Market Cap:
$176.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Coherus Oncology Inc
NASDAQ:CHRS
|
US |
|
P
|
Premium Textile Mills Ltd
KAR:PRET
|
PK |
|
Max Resource Corp
XTSX:MAX
|
CA |
|
C
|
Century Insurance Company Ltd
KAR:CENI
|
PK |
|
D
|
Darco Water Technologies Ltd
SGX:BLR
|
SG |
|
S
|
ShineMore Technology Materials Co Ltd
TPEX:8291
|
TW |
Wall St Price Targets
CHRS Price Forecast
Based on 6 analysts
Based on 6 analysts
+524% Upside
from
$1.145
today
Coherus Oncology Inc (CHRS)’s 12-month stock price forecast through October 2027 has a consensus target of $7.14, implying 524% upside. The forecast is based on price targets from 6 Wall Street analysts.
CHRS Analyst Rating
Based on 6 analysts
Based on 6 analysts
Analysts rate CHRS Strong buy, with 5 of 6 recommending Buy or Strong buy.
Coherus Oncology Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CHRS's stock price target?
Price Target
7.14
USD
7.14
USD
According to Wall Street analysts, the average 1-year price target for CHRS is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Coherus Oncology Inc?
Projected CAGR
46%
46%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 46%.
What is the Gross Profit forecast for Coherus Oncology Inc?
Projected CAGR
50%
50%
The compound annual growth rate for Gross Profit over the next 7 years is 50%.